Cosmos Health (COSM) said Monday it entered into a distribution agreement with Virax Biolabs (VRAX) to distribute Virax-branded Avian Influenza Virus Real-Time PCR Kits in major European and Gulf Cooperation Council markets.
Financial details weren't disclosed.
Cosmos Health secures exclusive distribution rights for the kits in Greece and Cyprus and non-exclusive rights in European markets, including France, Portugal, Spain, The Netherlands, Belgium, Sweden, Finland, Denmark, Norway, Germany, Switzerland, and Austria.
Cosmos Health said the non-exclusive rights also cover GCC countries Oman and Bahrain.
The agreement allows Cosmos Health to import, sell, and distribute ViraxClear-branded kits in the specified territories, with Virax Biolabs handling regulatory compliance and providing necessary documentation for product registration and approval.
Shares of Cosmos Health were down more than 6% in recent Monday trading, while Virax's were up 2.1%.
Price: 0.58, Change: -0.04, Percent Change: -6.15
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。